1.27 N/A 0.58% 0.00% Distribution costs (41.75 ) (24.14 ) (17.61 ) 72.95% (19.11%) (13.74%) Administrative expenses (95.74 ) (94.34 ) (1.40 ) 1.48% (43.82%) (53.71%) Other Expenses Impairment loss of
-27.5% -24.5% 2,120.4 1,782.4 -15.9% Other income 31.8 15.9 22.9 -28.1% +44.1% 51.7 38.7 -25.1% Selling and distribution expenses 587.2 536.7 463.7 -21.0% -13.6% 1,175.1 1,000.4 -14.9% Administrative
) % Revenue from sales and service 1,788.5 2,025.3 1,187.1 (236.8) (11.7) 601.4 50.7 Cost of sales and service 1,499.5 1,686.8 998.7 (187.3) (11.1) 500.8 50.1 Selling and distribution expenses 73.7 78.7 52.0
sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83
revenue Classified Loans and Allowance for Doubtful Accounts Million Baht Item Loans & Accrued Interest Receivables * Allowance for Doubtful Accounts Classified to Bank of Thailand Criteria June 2017 March
2,083,160 (0.6)% (3.2)% * Less deferred revenue Classified Loans and Allowance for Doubtful Accounts Million Baht Item Loans & Accrued Interest Receivables * Allowance for Doubtful Accounts Classified to Bank
Housing Real estate and construction Agriculture and mining Others Jun’20 V2 27/08/63 10 Classified Loans and Allowance for Expected Credit Losses Non-performing loan (Gross NPL) at the end of June 2020 was
Others 14.4% 14.1% 15.1% 2.9% 2.7% 2.5% 10.0% 9.9% 9.7% 12.3% 12.2% 11.5% 22.8% 22.4% 21.9% 37.6% 38.7% 39.3% Sep'19 Jun'19 Dec'18 V2 12/11/62 10 Classified Loans and Allowance for Doubtful Accounts